CYNTHIA ROGERS: Open Payments
NPI 1407842131 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 32 payments from 20 companies in 2025. Trend: 2023 $2,921 · 2024 $2,617 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 2 | $143 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Eisai Inc. | 4 | $78 |
| GENZYME CORPORATION | 3 | $61 |
| SpringWorks Therapeutics, Inc. | 1 | $41 |
| ABBVIE INC. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Vifor Pharma, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Gilead Sciences, Inc. | 1 | $28 |
Products named: Lenvima, ENHERTU, EPKINLY, OGSIVEO, CABLIVI, OPDIVO, Zemaira, Trodelvy.
Industry payments across TN — which companies pay providers there.
